Pharmacological inhibition of the key component of the Wnt signaling pathway GSK-3β, enhances neurogenesis in the hippocampus of AD mice (Fiorentini et al., 2010; Varela-Nallar et al., 2015; Zeng et al., 2019). Here, GSK3B is linked to Alzheimer disease.